stock ticker hero image

Investor relations

Our science-led strategy is key to delivering long-term value for patients, employees and shareholders.

NYSE: MRK
August 16, 2022 8:09 pm ET
Delayed at least 20 minutes

View stock information

Latest news, events & financials

View all

Our pipeline shows our relentless pursuit of the next breakthrough.

Phase II programs
75
Phase III programs
28
Under review
3
Illustration of leaders speaking on stage

Our leadership

Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy.

women harvesting tea leaves with basket

Corporate responsibility

Supporting the future of our business and the health and well-being of patients, people and communities around the world.

Download our 2020/2021 ESG Progress Report

We're led by our science

We follow the science to our next breakthrough, leaving no stone unturned.

View our stories
Innovation

Merck’s Q2 2022 earnings report

Merck’s (NYSE: MRK) Q2 2022 results deliver robust sales growth and important clinical advancements. The company announced Q2 worldwide sales of $14.6 billion, an increase of 28% from Q2 2021. “I continue to be immensely proud of how the Merck team is performing in all facets of our business – scientifically, commercially and operationally,” said Robert […]

Read more

Next: Merck’s Q2 2022 earnings report

Innovation

Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

Read more

Next: Our new London Discovery Research Center site

Innovation

Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

Read more

Next: Clinical trials bring our medicines and vaccines to life

Innovation

Merck’s Q2 2022 earnings report

Merck’s (NYSE: MRK) Q2 2022 results deliver robust sales growth and important clinical advancements. The company announced Q2 worldwide sales of $14.6 billion, an increase of 28% from Q2 2021. “I continue to be immensely proud of how the Merck team is performing in all facets of our business – scientifically, commercially and operationally,” said Robert […]

Read more

Next: Merck’s Q2 2022 earnings report

Innovation

Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

Read more

Next: Our new London Discovery Research Center site

Innovation

Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

Read more

Next: Clinical trials bring our medicines and vaccines to life

Previous
Next

Unsubscribe from email alerts

Contact us banner image
For questions, please contact our team.

Contact investor relations